Clinical Trial Detail

NCT ID NCT02537561
Title Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements no
Sponsors Washington University School of Medicine
Indications

non-small cell lung carcinoma

Advanced Solid Tumor

Therapies

Talazoparib

Cisplatin + Gemcitabine

Age Groups: adult

No variant requirements are available.